- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Amarin Corp PLC (AMRN)
| Open: | 6.5700 | Day's Range: | 6.5000 - 6.7150 | Volume: | 3,107,333 |
|---|---|---|---|---|---|
| Previous Close: | 6.6200 | 52wk Range: | 6.2500 - 15.9600 | 1-Yr Rtn: | -48.15% |
Key Statistics for AMRN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.2442 |
| Est. EPS (USD) (12/2013) | -1.3880 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 992.06 |
| Shares Outstanding (M) | 150.31 |
| 30 Day Average Volume | 3,702,301 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AMRN
Company Profile & Key Executives for AMRN
Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.
| Joseph S Zakrzewski "Joe"Chairman/CEO | John F TheroPresident/Asst Secy |
| Steven B Ketchum "Steve"Senior VP/Pres:Rsch & Dev | Paresh SoniSenior VP/Head:Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AMRN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page